Top
Begin typing your search above and press return to search.
keyboard_arrow_down
Login
exit_to_app
Two mind-sets: one here,  the other there
access_time 2021-01-20T13:57:46+05:30
What is Halal? Market strategies and controversy
access_time 2021-01-19T15:54:19+05:30
Arnabs chats cannot be ignored
access_time 2021-01-18T11:33:12+05:30
Women and girls need to be safe
access_time 2021-01-15T15:08:45+05:30
DEEP READAll arrow_drop_down
exit_to_app
Homechevron_rightLifestylechevron_rightHealthchevron_rightCentral Licensing...

Central Licensing Authority grants permission to manufacture 'Covaxin' for sale

text_fields
bookmark_border
Central Licensing Authority grants permission to manufacture Covaxin for sale
cancel

New Delhi: Hyderabad-based Bharat Biotech gets permission to manufacture 'Covaxin' for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergency use. According to an IANS report, The Central Licensing Authority on Saturday granted permission to Bharat Biotech International Ltd to manufacture for sale of the pharmaceutical formulation of Covaxin.

Earlier on Sunday, Drug Controller General of India (DCGI) V.G. Somani announced that Bharat Biotech's 'Covaxin' has been approved for "restricted use in emergency situation". The approval has also been given to Serum Institute of India's 'Covishield' vaccine.

The Subject Expert Committee of Central Drugs Standards Control Organisation had recommended restricted use of Covaxin "in emergency situation in public interest as an abundant precaution, in clinical trial mode, specially in the context of infection by mutant strains". Officals say that it will be used as backup in case of spike in cases.

Covaxin has to be administered in two doses and can be stored at 2-8 degree Celsius. This is a major relief for India which has the second highest number of infections in the world after the US.

"Covaxin has generated excellent safety data with robust immune responses to multiple viral proteins that persist," Krishna Ella, Chairman and Managing Director of the pharmaceutical firm said following the approval.

Bharat Biotech is India's first indigenous vaccine for coronavirus. The inactivated virus vaccine is developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).

( From IANS with edits)

Show Full Article
TAGS:Covaxin Bharat Biotech Covid Updates 
Next Story